Franco-Nevada About To Put More Money In Your Pocket (FNV)

Looking at the universe of stocks we cover at Dividend Channel, on 1/14/14, Franco-Nevada Corp (FNV) will trade ex-dividend, for its monthly dividend of $0.06, payable on 1/30/14. As a percentage of FNV's recent stock price of $41.87, this dividend works out to approximately 0.14%.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for FNV, showing historical dividends prior to the most recent $0.06 declared by Franco-Nevada Corp:

FNV+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from FNV is likely to continue, and whether the current estimated yield of 1.72% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of FNV shares, versus its 200 day moving average:

Franco-Nevada Corp 200 Day Moving Average Chart

Looking at the chart above, FNV's low point in its 52 week range is $31.54 per share, with $56.9325 as the 52 week high point — that compares with a last trade of $41.93.

According to the ETF Finder at ETF Channel, FNV makes up 4.47% of the Gold Miners ETF ( GDX) which is trading up by about 2.1% on the day Friday.

In Friday trading, Franco-Nevada Corp shares are currently up about 1.1% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says